Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467; NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL): A Groupwide Phase III StudyCIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
